Allos
QuietFiled to raiseCincinnati, OHEnergy, Biotechnology, HealthcareLast fund filed February 2022
4 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Allos IV-Q | February 2022 | $38M | $38M | 43 |
| Allos IVFiled to raise in 2021, with no closing reported yet. | 2021 | $75M | $0 | 0 |
| Allos III | December 2018 | $6.8M | $6.8M | 28 |
| Allos III-Q | December 2018 | $45M | $45M | 65 |
| Allos Scale Special Investment Fund | March 2014 | $1M | $2.3M | 30 |
| Allos I-B | March 2014 | $1.5M | $1.5M | 36 |
| Allos II-Q | March 2012 | $39M | $18M | 72 |
| Allos II | March 2012 | $10M | $4M | 21 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
5 partners are named across this firm’s filings, 4 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| David Kerr | Quiet | Climate & energy, Enterprise software, Sales & marketing tech | 14 | 0 |
| Don Aquilano | Quiet | Enterprise software, HR & future of work | 12 | 0 |
| John McIllwraithNot on the current fund | Quiet | Medical devices | 1 | 0 |
| John McIlwraith | Quiet | Enterprise software, Climate & energy, Digital health | 10 | 0 |
| Julie Whitehead | Quiet | None listed | 1 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of Allos’s own portfolio companies, based on 20 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Allos’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| High Alpha | 4 | CTOS Software, Docket HQ, ENCAMP, OCTIV |
| Wireframe Ventures | 2 | ASSURERX HEALTH, BLUE PILLAR |
| Edison Partners | 1 | Emplify |
| Greycroft | 1 | OCTIV |
| Openview Venture Partners | 1 | ENCAMP |
| Plymouth Growth Partners | 1 | Traction Ag |
A shared board seat: a company where filings name a Allos partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.